The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Type I interferon in the pathogenesis of systemic lupus erythematosus
Open accessAbstract
Type I interferon (IFN) is a primary pathogenic factor in systemic lupus erythematosus (SLE). Gain-of-function genetic variants in the type I IFN pathway have been associated with risk of disease. Common polygenic as well as rare monogenic influences on type I IFN have been demonstrated, supporting a complex genetic basis for high IFN in many SLE patients. Both SLE-associated autoantibodies and high type I IFN can be observed in the pre-disease state. Patients with SLE and evidence of high type I IFN have more active disease and a greater propensity to nephritis and other severe manifestations. Despite the well-established association between type I IFN and SLE, the specific triggers of type I IFN production, the mechanisms by which IFNs help perpetuate the cycle of autoreactive cells and autoantibody production are not completely clear. This review provides an updated overview of type I IFN in SLE pathogenesis, clinical manifestations, and current therapeutic strategies targeting this pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Morand, E. F., Furie, R., Tanaka, Y., Bruce, I. N., Askanase, A. D., Richez, C., Bae, S.-C., Brohawn, P. Z., Pineda, L., Berglind, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912196 · Cited by 1,379
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
Remmers, E. F., Plenge, R. M., Lee, A. T., Graham, R. R., Hom, G., Behrens, T. W., de Bakker, P. I. W., Le, J. M., Lee, H.-S., Batliwalla, F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073003 · Cited by 1,041
Kirou, K. A., Lee, C., George, S., Louca, K., Peterson, M. G. E., & Crow, M. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21031 · Cited by 701
Plasmacytoid Dendritic Cells: Development, Regulation, and Function
Reizis, B. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.027 · Cited by 673
Discriminating self from non-self in nucleic acid sensing
Schlee, M., & Hartmann, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.78 · Cited by 593
Wallace, D. J., Furie, R. A., Tanaka, Y., Kalunian, K. C., Mosca, M., Petri, M. A., Dörner, T., Cardiel, M. H., Bruce, I. N., Gomez, E., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31363-1 · Cited by 513
Furie, R. A., Morand, E. F., Bruce, I. N., Manzi, S., Kalunian, K. C., Vital, E. M., Lawrence Ford, T., Gupta, R., Hiepe, F., Santiago, M., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30076-1 · Cited by 512
Khamashta, M., Merrill, J. T., Werth, V. P., Furie, R., Kalunian, K., Illei, G. G., Drappa, J., Wang, L., & Greth, W. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208562 · Cited by 503
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Transancestral mapping and genetic load in systemic lupus erythematosus
Langefeld, C. D., Ainsworth, H. C., Graham, D. S. C., Kelly, J. A., Comeau, M. E., Marion, M. C., Howard, T. D., Ramos, P. S., Croker, J. A., Morris, D. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms16021 · Cited by 420
Self-citationHigh serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
Niewold, T. B., Hua, J., Lehman, T. J. A., Harley, J. B., & Crow, M. K. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364408 · Cited by 416
Self-citationthe Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Der, E., Suryawanshi, H., Morozov, P., Kustagi, M., Goilav, B., Ranabothu, S., Izmirly, P., Clancy, R., Belmont, H. M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0386-1 · Cited by 403
Kalunian, K. C., Merrill, J. T., Maciuca, R., McBride, J. M., Townsend, M. J., Wei, X., Davis, J. C., & Kennedy, W. P. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206090 · Cited by 340
Type I interferon in rheumatic diseases
Muskardin, T. L. W., & Niewold, T. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.31 · Cited by 308
Self-citationCoit, P., Jeffries, M., Altorok, N., Dozmorov, M. G., Koelsch, K. A., Wren, J. D., Merrill, J. T., McCune, W. J., & Sawalha, A. H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.04.003 · Cited by 303
Weckerle, C. E., & Niewold, T. B. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8192-4 · Cited by 300
Self-citationMonoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Furie, R. A., Werth, V. P., Merola, J. F., Stevenson, L. F., Reynolds, T. L., Naik, H., Wang, W., Christmann, R., Gardet, A., Pellerin, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124466 · Cited by 300
Rönnblom, L., & Alm, G. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.f59 · Cited by 288
Microarray Analysis of Interferon-regulated Genes in SLE
Crow, M. K., Kirou, K. A., & Wohlgemuth, J. (2003) · Autoimmunity · doi:10.1080/08916930310001625952 · Cited by 287
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal, G., Gunnarsson, I., Rönnelid, J., Rogberg, S., Klareskog, L., & Lundberg, I. E. (2000) · PubMed · Cited by 287
Sarkar, M. K., Hile, G. A., Tsoi, L. C., Xing, X., Liu, J., Liang, Y., Berthier, C. C., Swindell, W. R., Patrick, M. T., Shao, S., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213197 · Cited by 279
Mistry, P., Nakabo, S., O’Neil, L., Goel, R. R., Jiang, K., Carmona-Rivera, C., Gupta, S., Chan, D. W., Carlucci, P. M., Wang, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908576116 · Cited by 278
Niewold, T. B., Kelly, J. A., Flesch, M. H., Espinoza, L. R., Harley, J. B., & Crow, M. K. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23613 · Cited by 269
Self-citationWeckerle, C. E., Franek, B. S., Kelly, J. A., Kumabe, M., Mikolaitis, R. A., Green, S. L., Utset, T. O., Jolly, M., James, J. A., Harley, J. B., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30187 · Cited by 259
Self-citationMunroe, M. E., Lu, R., Zhao, Y. D., Fife, D. A., Robertson, J. M., Guthridge, J. M., Niewold, T. B., Tsokos, G. C., Keith, M. P., Harley, J. B., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208140 · Cited by 256
Self-citationGenetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
Sisirak, V., Ganguly, D., Lewis, K. L., Couillault, C., Tanaka, L., Bolland, S., D’Agati, V., Elkon, K. B., & Reizis, B. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132522 · Cited by 234
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9
Heinz, L. X., Lee, J., Kapoor, U., Kartnig, F., Sedlyarov, V., Papakostas, K., César-Razquin, A., Essletzbichler, P., Goldmann, U., Stefanovic, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2282-0 · Cited by 229
Immunogenetics of systemic lupus erythematosus: A comprehensive review
Ghodke-Puranik, Y., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.004 · Cited by 225
Self-citationIntracellular Nucleic Acid Detection in Autoimmunity
Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E., & Stetson, D. B. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052331 · Cited by 223
Kariuki, S. N., Kirou, K. A., MacDermott, E. J., Barillas-Arias, L., Crow, M. K., & Niewold, T. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.34 · Cited by 222
Self-citationOke, V., Gunnarsson, I., Dorschner, J., Eketjäll, S., Zickert, A., Niewold, T. B., & Svenungsson, E. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1878-y · Cited by 215
Self-citationLee-Kirsch, M. A. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104506 · Cited by 210
Soni, C., Perez, O. A., Voss, W. N., Pucella, J. N., Serpas, L., Mehl, J., Ching, K. L., Goike, J., Georgiou, G., Ippolito, G. C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.015 · Cited by 204
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
Petri, M., Singh, S., Tesfasyone, H., Dedrick, R., Fry, K., Lal, P., Williams, G., Bauer, J., Gregersen, P., Behrens, T., et al. (2009) · Lupus · doi:10.1177/0961203309105529 · Cited by 182
Human DNA-PK activates a STING-independent DNA sensing pathway
Burleigh, K., Maltbaek, J. H., Cambier, S., Green, R., Gale, M., James, R. C., & Stetson, D. B. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba4219 · Cited by 175
Salloum, R., Franek, B. S., Kariuki, S. N., Rhee, L., Mikolaitis, R. A., Jolly, M., Utset, T. O., & Niewold, T. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27182 · Cited by 159
Self-citationRobinson, T., Kariuki, S. N., Franek, B. S., Kumabe, M., Kumar, A. A., Badaracco, M., Mikolaitis, R. A., Guerrero, G., Utset, T. O., Drevlow, B. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100857 · Cited by 159
Self-citationSystemic lupus erythematosus and the type I interferon system.
Rönnblom, L., & Alm, G. V. (2003) · Arthritis Research · doi:10.1186/ar625 · Cited by 158
Kumaran Satyanarayanan, S., El Kebir, D., Soboh, S., Butenko, S., Sekheri, M., Saadi, J., Peled, N., Assi, S., Othman, A., Schif-Zuck, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10903-9 · Cited by 158
Interferon Alpha as a Primary Pathogenic Factor in Human Lupus
Niewold, T. (2011) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2011.0071 · Cited by 153
Self-citationBaccalà, R., González‐Quintial, R., Blasius, A. L., Rimann, I., Ozato, K., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222798110 · Cited by 153
Self-Awareness: Nucleic Acid–Driven Inflammation and the Type I Interferonopathies
Uggenti, C., Lepelley, A., & Crow, Y. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041257 · Cited by 150
Odhams, C. A., Roberts, A. L., Vester, S. K., Duarte, C., Beales, C. T., Clarke, A. J., Lindinger, S., Daffern, S. J., Zito, A., Chen, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10106-2 · Cited by 144
Niewold, T. B., Kelly, J. A., Kariuki, S. N., Franek, B. S., Kumar, A., Kaufman, K. M., Thomas, K., Walker, D. J., Kamp, S., Frost, J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200463 · Cited by 142
Self-citationUNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity
Majer, O., Liu, B., Kreuk, L. S. M., Krogan, N. J., & Barton, G. M. (2019) · Nature · doi:10.1038/s41586-019-1612-6 · Cited by 136
Skopelja‐Gardner, S., An, J., Tai, J., Tanaka, L., Sun, X., Hermanson, P., Baum, R., Kawasumi, M., Green, R. R., Gale, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64865-w · Cited by 136
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
Jiang, S., Athanasopoulos, V., Ellyard, J. I., Chuah, A., Cappello, J. Y., Cook, A., Prabhu, S. B., Cardenas, J., Gu, J., Stanley, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10242-9 · Cited by 132
Mathian, A., Mouries-Martin, S., Dorgham, K., Devilliers, H., Yssel, H., Castillo, L. N. G., Aubart, F. C., Haroche, J., Hié, M., de Chambrun, M. P., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215571 · Cited by 122
Hagberg, N., Joelsson, M., Leonard, D., Reid, S., Eloranta, M., Mo, J., Nilsson, M., Syvänen, A.-C., Bryceson, Y. T., & Rönnblom, L. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212794 · Cited by 110
Houssiau, F., Thanou, A., Mazur, M., Ramiterre, E., Mora, D. A. G., Misterska-Skóra, M., Perich-Campos, R. A., Smakotina, S. A., Cruz, S. C., Louzir, B., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216379 · Cited by 108
Kariuki, S. N., Franek, B., Kumar, A. A., Arrington, J., Mikolaitis, R., Utset, T., Jolly, M., Crow, M., Skol, A., & Niewold, T. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3101 · Cited by 106
Self-citationPothlichet, J., Niewold, T. B., Vitour, D., Solhonne, B., Crow, M. K., & Si‐Tahar, M. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000120 · Cited by 105
Self-citationB cell–intrinsic TLR9 expression is protective in murine lupus
Tilstra, J. S., John, S. A., Gordon, R. A., Leibler, C., Kashgarian, M. J., Bastacky, S., Nickerson, K. M., & Shlomchik, M. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132328 · Cited by 93
Mavragani, C. P., Nezos, A., Sagalovskiy, I., Seshan, S., Kirou, K. A., & Crow, M. K. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.004 · Cited by 85
Genetics of the type I interferon pathway in systemic lupus erythematosus
Ghodke‐Puranik, Y., & Niewold, T. B. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.58 · Cited by 77
Self-citationChen, S., Pu, W., Guo, S., Li, J., He, D., & Wang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00223 · Cited by 76
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy
Hong, S., Banchereau, R., Maslow, B.-S. L., Guerra, M. M., Cardenas, J., Baisch, J. M., Branch, D. W., Porter, T. F., Sawitzke, A. D., Laskin, C. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190185 · Cited by 76
Familial Aggregation of Autoimmune Disease in Juvenile Dermatomyositis
Niewold, T. B., Wu, S., Smith, M. K., Morgan, G. A., & Pachman, L. M. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3022 · Cited by 72
Self-citationFetter, T., Smith, P. A., Guel, T., Braegelmann, C., Bieber, T. R. M., & Wenzel, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00344 · Cited by 69
Ritterhouse, L. L., Crowe, S. R., Niewold, T. B., Merrill, J. T., Roberts, V., Dedeke, A. B., Neas, B. R., Thompson, L. F., Guthridge, J. M., & James, J. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30598 · Cited by 68
Self-citationKariuki, S. N., Ghodke-Puranik, Y., Dorschner, J. M., Chrabot, B., Kelly, J., Tsao, B., Kimberly, R., Alarcón-Riquelme, M., Jacob, C., Criswell, L., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.57 · Cited by 68
Self-citationTLRs and interferons: a central paradigm in autoimmunity
Kono, D. H., Baccalà, R., & Theofilopoulos, A. N. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.006 · Cited by 65
Wolf, S., Estadt, S. N., Theros, J. S., Moore, T., Ellis, J. S., Liu, J. J., Reed, T. J., Jacob, C. O., Gudjonsson, J. E., & Kahlenberg, J. M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.06.002 · Cited by 64
Niewold, T. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000205 · Cited by 58
Self-citationSUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response
Crowl, J. T., & Stetson, D. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802114115 · Cited by 56
DNA as a self-antigen: nature and regulation
Soni, C., & Reizis, B. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.009 · Cited by 46
Jensen, M. A., Patterson, K. C., Kumar, A., Kumabe, M., Franek, B. S., & Niewold, T. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202024 · Cited by 33
Self-citationGhodke‐Puranik, Y., Dorschner, J. M., Vsetecka, D. M., Amin, S., Makol, A., Ernste, F. C., Osborn, T. G., Moder, K. G., CHOWDHARY, V. R., Eliopoulos, E., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40304 · Cited by 29
Self-citationA Successful Trial for Lupus — How Good Is Good Enough?
Salmon, J. E., & Niewold, T. B. (2019) · New England Journal of Medicine · doi:10.1056/nejme1915490 · Cited by 20
Self-citationGonzález‐Quintial, R., Nguyen, A., Kono, D. H., Oldstone, M. B. A., Theofilopoulos, A. N., & Baccalà, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203118 · Cited by 19
Drugs in early clinical development for Systemic Lupus Erythematosus
Postal, M., Sinicato, N. A., Appenzeller, S., & Niewold, T. B. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1162291 · Cited by 15
Self-citationGao, L., OConnell, M., Allen, M., Liesveld, J. L., McDavid, A., Anolik, J. H., & Looney, R. J. (2019) · Cytokine · doi:10.1016/j.cyto.2019.05.012 · Cited by 15
Koldobskaya, Y., Ko, K., Kumar, A., Agik, S., Arrington, J., Kariuki, S. N., Franek, B. S., Kumabe, M., Utset, T. O., Jolly, M., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/682018 · Cited by 14
Self-citation
Cited by
Autoantibodies against complement component C1q in systemic lupus erythematosus
Trendelenburg, M. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1279 · Cited by 48
Metadata
- Authors
- Postal, M., Vivaldo, J. F., Fernandez-Ruiz, R., Paredes, J. L., Appenzeller, S., & Niewold, T. B.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 67
- Pages
- 87-94
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W3107031282
- Cited by
- 306
- References
- 81
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.